Monday, 27 May 2019

Pharma News

  • Innovation in drug delivery system is in a constant state of evolution'

    Pharma |  Opinion | By Nandita Singh | 0 Comment | 14 Mar, 2012

    Ms Prasanna Vadhana Kannan is the industry analyst in medical devices & diagnostic imaging for Frost & Sullivan Asia Pacific. One of the notable advances transforming the field of ...Read more

  • Takeda's center among Chicago's top 100 workplaces

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 14 Nov, 2012

    Singapore: Takeda Pharmaceuticals' Deerfield campus has been listed among Chicago's top 100 workplaces by the Chicago Tribune. The list of the best places to work in the Chicago area is ba...Read more

  • Eisai seeks nod for Helicobacter Pylori treatment

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 01 Jun, 2012

    Singapore: Eisai, which has its headquarters in Tokyo, has submitted a marketing authorization application to Japan's Ministry of Health, Labor and Welfare for approval of two types of new ...Read more

  • Will Keryx's ferric citrate NDA get nod in Japan?

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 08 Jan, 2013

    Singapore: Keryx Biopharmaceuticals announced that its Japanese partner, Japan Tobacco (JT), has filed a New Drug Application (NDA) with the Japanese Ministry of Health, Labour and Welfare...Read more

  • Study shows effectiveness of MSD's Januvia

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 29 Jun, 2012

    Singapore: A new study published in Current Medical Research & Opinion (CMRO) showed that people with type 2 diabetes who chose to fast during Ramadan and were switched to MSD's Januvia...Read more

  • VM202 trial completes patient administration

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 13 Jun, 2013

    Singapore: ViroMed, a leading biotechnology company, announced the final enrollment and administration of 105 patients for the company's ongoing phase II clinical trial of VM202-DPN in US/K...Read more

  • FDA accepts sNDA for Astellas cancer drug

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 17 Jan, 2013

    Singapore: The US FDA has accepted Astellas Pharma's US subsidiary filing of a supplemental New Drug Application (sNDA) for Tarceva (erlotinib) for first-line use in people with locally adv...Read more

  • AstraZeneca, BMS gets FDA nod for diabetes drug

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 09 Jan, 2014

    Singapore: AstraZeneca and Bristol-Myers Squibb have recieved U.S. Food and Drug Administration (FDA) approval for diabetes drug Farxiga (dapagliflozin). AstraZeneca and Bristol-Myers Squi...Read more

  • EMA to review marketing plea for antipsychotic medication

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 29 Oct, 2012

    Singapore: The European Medicines Agency (EMA) has accepted the marketing authorization application for review of an atypical antipsychotic medication lurasidone hydrochloride. The product ...Read more

  • Leo launches psoriasis education program

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 30 Jan, 2013

    Singapore: Leo Pharma launched Psoriasis Coach All-Round Education (PsorCARE) program in Singapore on January 26, 2013. Developed by LEO Pharma Asia and PsorAsia, PsorCARE's goal is to enh...Read more

  • Chipscreen gets SFDA nod after accelerated review

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 17 Apr, 2013

    ‎Singapore: China-based Chipscreen Biosciences announced the achievement of the primary endpoint in the pivotal, registrational phase II Chipel trial of Chidamide (Epidaza), an orally...Read more

  • Bird flu cases erupt in Cambodia

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 04 Feb, 2013

    Singapore: Cambodia's Ministry of Health (MoH) has reported five new human cases of avian influenza (bird flu), which were confirmed positive for the H5N1 virus in January 2013. The five ...Read more

  • Indian pharma clocks 8.9% growth in June 2013: IMS

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 24 Jul, 2013

    New Delhi: The IMS Health Total Sales Audit (TSA) has released a report stating that the Indian pharmaceutical market has clocked a growth of 8.9 percent during the month of June 2013. The...Read more

  • Sanofi withdraws diabetes drug NDA in the US

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 13 Sep, 2013

    Singapore: Global pharmaceutical company, Sanofi has temporarily withdrawn new drug application (NDA) for lixisenatide in the US and plans to resubmit in 2015.Lixisenatide is approved in Eu...Read more

  • Antithrombotic drug market to be $24 bn by 2015

    Pharma |  Analysis | By BioSpectrum Bureau  | 0 Comment | 18 Feb, 2013

    Singapore: Visiongain, a business information provider, estimates in its report 'Antithrombotic Drugs: World Market 2013-2023' that the global antithrombotic drug market to reach revenue of...Read more

  • Ranbaxy advisory: All our products are safe and efficacious

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 03 Jun, 2013

    New Delhi: Ranbaxy issued an advisory claiming that all their products in the Indian and global markets are safe and efficacious. The firm revealed that the advisory was issued in public i...Read more

  • Amgen to acquire Onyx for $10 bn cash

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 26 Aug, 2013

    Singapore: Global biopharmaceutical company Amgen plans to acquire all the outstanding shares of Onyx Pharmaceuticals for $125-per-share, totalling to $10.40 billion, in cash. The deal woul...Read more

  • Rabies claims 100 lives annually in Vietnam: UN

    Pharma |  Analysis | By BioSpectrum Bureau  | 0 Comment | 30 Sep, 2013

    Singapore: Vietnam has seen a substantial increase in the number of rabies fatalities from 34 deaths in 2003 to 131 deaths in 2007, according to United Nations (UN). World Rabies Day, whic...Read more



Survey Box

Will stem cell therapy market witness highest growth in Asia by 2020?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls